QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach

詳細情報 詳細情報について

• CRID

  1360857597016940928

• DOI

  10.1007/s13346-020-00803-7

• ISSN

  21903948

  2190393X

• Web Site

  https://link.springer.com/content/pdf/10.1007/s13346-020-00803-7.pdf

  https://link.springer.com/article/10.1007/s13346-020-00803-7/fulltext.html

• データソース種別

  • Crossref